Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions

Details for Australian Patent Application No. 2009281809 (hide)

Owner Osiris Therapeutics, Inc.

Inventors Danilkovich, Alla; Newman, Robert E.; Tom, Samson; Ton, Christopher; Wang, Zhanling; Young, Randal

Agent Spruson & Ferguson

Pub. Number AU-A-2009281809

PCT Pub. Number WO2010/019886

Priority 61/088,898 14.08.08 US

Filing date 14 August 2009

Wipo publication date 18 February 2010

International Classifications

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/019886 Priority application(s): WO2010/019886

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009281822-cMET inhibitors

2009281808-Spatial light modulator (SLM)-based optical attenuator